T43.014 Poisoning by tricyclic antidepressants, undetermined

Name of the Condition

• Poisoning by tricyclic antidepressants, undetermined
• Technical term: T43.014

Summary

This code applies to poisoning by tricyclic antidepressants (TCAs) when the intent is not specified or cannot be determined. TCAs are a class of medications used to treat depression, anxiety, and other mental health conditions. The code is used when clinical documentation does not clearly indicate whether the exposure was accidental, intentional, or therapeutic, and the outcome is classified as poisoning.

Causes

Poisoning may result from accidental or intentional overdose, incorrect dosing, or an abnormal reaction to the drug. Undetermined intent often occurs when documentation lacks clarity about the circumstances of exposure, such as when a patient presents with symptoms but the history is incomplete or ambiguous. Therapeutic use with adverse effects is excluded from this code.

Risk Factors

• Concurrent use of multiple medications that interact with TCAs.
• Pre-existing conditions affecting drug metabolism (e.g., liver or kidney disease).
• Lack of access to healthcare or medication guidance.
• Unclear or incomplete patient history regarding medication use.

Symptoms

Symptoms of tricyclic antidepressant poisoning can include:

• Altered mental status, confusion, or sedation.
• Nausea, vomiting, or gastrointestinal distress.
• Changes in heart rate or blood pressure.
• Dry mouth, blurred vision, or urinary retention.
• Seizures, tremors, or muscle rigidity.

Diagnosis

Diagnosis is based on clinical presentation, medication history, and laboratory testing. Healthcare providers assess symptoms, review medication records, and may use toxicology screens to confirm TCA exposure. Documentation must support the presence of poisoning, with intent classified as undetermined when no clear evidence of accidental or intentional exposure exists.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further absorption. This may include activated charcoal, intravenous fluids, and cardiac monitoring. Specific antidotes or supportive care are used based on the severity of symptoms. The approach depends on the patient's clinical status and underlying conditions.

Prognosis and Follow-Up

Prognosis varies based on the dose ingested, time to treatment, and patient factors. Early intervention improves outcomes. Follow-up care may involve monitoring for delayed effects, assessing mental health, and ensuring safe medication management. Long-term follow-up is recommended for patients with undetermined intent to address potential risks.

Complications

Complications can include cardiac arrhythmias, seizures, respiratory depression, or organ damage. Severe cases may lead to coma or death. Undetermined intent increases the risk of recurrence if underlying issues, such as medication misuse or mental health concerns, are not addressed.

Lifestyle & Prevention

Prevention strategies include proper medication storage, clear dosing instructions, and regular follow-up with healthcare providers. Patients should be educated on the risks of TCA overdose and the importance of adhering to prescribed regimens. Secure storage and supervision may reduce accidental exposure.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, such as confusion, irregular heartbeat, or seizures. Prompt evaluation is critical for managing toxicity and preventing complications. Healthcare providers should be consulted for any concerns about medication use or potential overdose.

Tips for Medical Coders

This code is assigned when the intent of TCA exposure is undetermined. Documentation must support the presence of poisoning without clear evidence of accidental or intentional self-harm. Coders should verify that the clinical record lacks specificity on intent and that the outcome is classified as poisoning, not adverse effect or underdosing.